Conditions:
Hepatocellular Carcinoma
Prostate Cancer
Sponsor: AstraZeneca
trial.available_in:
БГ
Overview
Master LTFU study will monitor the long-term safety and tolerability of cell or gene therapy study participants from AstraZeneca for up to 15 years post last cell or gene therapy treatment.
Description
This is a multi-centre and multinational basket study that will monitor the long-term safety and tolerability of cell or gene therapies in participants that have taken part in other AstraZeneca cell or gene therapy studies for up to 15 years.
Who can participate
Inclusion Criteria:
1. The participant has received a cell or gene therapy in another AstraZeneca protocol.
2. Provision of signed and dated, written informed consent before any study-specific procedures.
Exclusion Criteria:
Not applicable
\-
БГ